Finance

Lists
Why is NBTX down 7.71%?
Dive Deeper
NBTX:NASDAQ
Nanobiotix SA - ADR
$ 25.75
-7.71%
(-2.15) 1D
10-р сарын 2, 16:00:00 (GMT-4)  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for NBTX...
Open
$ 27.39
High
$ 27.42
Low
$ 25.23
Mkt. cap
1.34 тэрбум
Avg. vol.
149.36 мян
Volume
255.77 мян
52-wk high
$ 57.00
52-wk low
$ 14.78
EPS
-$ 1.22
Beta
0.74
Shares outstanding
50.62 сая
No. of employees
98
Open
$ 27.39
High
$ 27.42
Low
$ 25.23
Mkt. cap
1.34 тэрбум
Avg. vol.
149.36 мян
Volume
255.77 мян
52-wk high
$ 57.00
52-wk low
$ 14.78
EPS
-$ 1.22
Beta
0.74
Shares outstanding
50.62 сая
No. of employees
98
News stories
From web sources and news partners
Profile
Nanobiotix is a biotechnology company that uses nanomedicine to develop new radiotherapy techniques for cancer patients. The company is headquartered in Paris, with additional corporate offices in New York and Massachusetts. Wikipedia
About Nanobiotix SA - ADR
CEOLaurent Levy
Employees98
Founded2003
Headquarters-
Sector-
Analyst ratings
Based on 3 analysts giving stock ratings to NBTX in the past 3 months
Buy
Buy
2
Hold
1
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for NBTX in the last 3 months.
Highest
Current $ 25.75
$ 64.00 (+148.54%)
Average
$ 47.00 (+82.52%)
Lowest
$ 30.00 (+16.50%)
Analyst
Recommendation
Action
Price target
Projected
Date
Paul Jeng
Guggenheim
Buy
Maintained
$ 64.00
+148.5%
09/25/2026
David Dai
UBS
Hold
Maintained
$ 30.00
+16.5%
09/25/2026
Tara Bancroft
TD Cowen
Buy
Maintained
-
-
09/25/2026
Michael Schmidt
Guggenheim
Buy
Reiterated
$ 36.00
+39.8%
05/05/2026
Jonathan Chang
Leerink Partners
Buy
Maintained
$ 37.00
+43.7%
04/01/2026
Unknown Analyst
Guggenheim
Buy
Maintained
$ 26.00
+1%
02/05/2026
Previous reportsAll values in EUR
Loading Previous Earnings...
Revenue
Net income
All values in EUR
2025 оны 9-р сар
2025 оны 12-р сар
2026 оны 3-р сар
2026 оны 6-р сар
Revenue
2.98 сая
2.98 сая
2.78 сая
2.78 сая
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
4.29 сая
4.29 сая
6.36 сая
6.36 сая
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
4.53 сая
4.53 сая
5.38 сая
5.38 сая
Operating expense
8.83 сая
8.83 сая
11.74 сая
11.74 сая
Total operating expenses
8.83 сая
8.83 сая
11.74 сая
11.74 сая
Operating income
-5.85 сая
-5.85 сая
-8.96 сая
-8.96 сая
Other non operating income
-8.50 мян
-8.50 мян
555.50 мян
555.50 мян
EBT including unusual items
-9.29 сая
-9.29 сая
-17.14 сая
-17.14 сая
EBT excluding unusual items
-8.57 сая
-8.57 сая
-17.14 сая
-17.14 сая
Income tax expense
-1.50 мян
-1.50 мян
8.00 мян
8.00 мян
Effective tax rate
0.02%
0.02%
-0.05%
-0.05%
Other operating expenses
-
-
-
-
Net income
-9.29 сая
-9.29 сая
-17.14 сая
-17.14 сая
Net profit margin
-311.97%
-311.97%
-617.69%
-617.69%
Earnings per share
-
-
-
-
Interest and investment income
193.50 мян
193.50 мян
-
-
Interest expense
-3.08 сая
-3.08 сая
-8.73 сая
-8.73 сая
Net interest expenses
-2.88 сая
-2.88 сая
-8.73 сая
-8.73 сая
Depreciation and amortization charges
-
-
-
-
EBITDA
-5.79 сая
-5.79 сая
-8.57 сая
-8.57 сая
Gain or loss from assets sale
76.50 мян
76.50 мян
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google аппс